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Abstract
Background: Cone photoreceptors are responsible for color and central vision. In the late stage of retinitis pigmentosa and
in geographic atrophy associated with age-related macular degeneration, cone degeneration eventually causes loss of
central vision. In the present work, we investigated cone degeneration secondary to rod loss in the S334ter-3 transgenic rats
carrying the rhodopsin mutation S334ter.
Methodology/Principal Findings: Recombinant human ciliary neurotrophic factor (CNTF) was delivered by intravitreal
injection to the left eye of an animal, and vehicle to the right eye. Eyes were harvested 10 days after injection. Cone outer
segments (COS), and cell bodies were identified by staining with peanut agglutinin and cone arrestin antibodies in whole-
mount retinas. For long-term treatment with CNTF, CNTF secreting microdevices were implanted into the left eyes at
postnatal day (PD) 20 and control devices into the right eyes. Cone ERG was recorded at PD 160 from implanted animals.
Our results demonstrate that an early sign of cone degeneration is the loss of COS, which concentrated in many small areas
throughout the retina and is progressive with age. Treatment with CNTF induces regeneration of COS and thus reverses the
degeneration process in early stages of cone degeneration. Sustained delivery of CNTF prevents cones from degeneration
and helps them to maintain COS and light-sensing function.
Conclusions/Significance: Loss of COS is an early sign of secondary cone degeneration whereas cell death occurs much
later. At early stages, degenerating cones are capable of regenerating outer segments, indicating the reversal of the
degenerative process. Sustained delivery of CNTF preserves cone cells and their function. Long-term treatment with CNTF
starting at early stages of degeneration could be a viable strategy for preservation of central vision for patients with retinal
degenerations.
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Introduction
Retinal degenerations are a major cause of blindness for which
no effective treatments are available [1]. It is estimated that one in
3,500 to 4,000 people are affected by retinitis pigmentosa (RP), a
heterogeneous group of inherited retinal degenerative disorders.
Mutations in at least 34 genes are identified to be responsible for
RP [1]. Most mutations responsible for the RP phenotype
selectively affect rod photoreceptors, nevertheless cones undergo
degeneration secondary to the loss of rods, often leading to total
blindness [1,2]. How to save the cones has become a major
research challenge.
A number of neurotrophic factors have demonstrated neuro-
protective effects in mitigating retinal degenerations [3]. Among
them, (CNTF ciliary neurotrophic factor) has shown a promising
capability to inhibit progression of retinal degenerations in a
variety of animal models, as well as in light-induced damage [4–
12]. CNTF, initially identified as a factor in chick embryo extract
that supported viability of embryonic chick ciliary neurons [13,14]
and later purified to homogeneity [15,16], exhibits multiple
biological effects in the retina. CNTF promotes the survival and
axonal regeneration of retinal ganglion cells [17–20] and acts as
neuronal differentiation factor, promotes the differentiation of a
subclass of cone photoreceptors expressing green opsin in the
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developing chick retina [21–23], enhances the expression of
bipolar neuron markers in rat retinal cultures [24–26], and inhibits
rod photoreceptor cell differentiation [22,25–27], and promotes
Mu¨ller glia genesis from the postnatal retinal progenitor pool [28].
It has been reported that CNTF regulates the phototransduction
machinery of rod photoreceptors, and the regulation was mediated
through Mu¨ller cells [29,30].
In the present study, we investigated the secondary degenera-
tion of cones in transgenic rats carrying the rhodopsin mutation
S334ter, a model of retinal degeneration. In this model, rod
photoreceptors undergo rapid degeneration soon after birth [31].
Cone degeneration starts at the peak of rod degeneration, and is
characterized by loss of COS in many round or irregularly shaped
areas across the retina. When treated with CNTF, cones are
stimulated to regenerate their COS. These results provide
evidence that in early stages, CNTF reverses secondary cone
degeneration. In addition, our results show that sustained delivery
of CNTF helps cones to maintain COS and their functions.
Results
Loss of COS in Early Stages of Cone Degeneration
The degeneration rate of homozygous S334ter-3 rats (Fig. 1) is
quite similar to that observed in the heterozygous animals [31].
Pyknotic nuclei are readily seen by postnatal day (PD) 10. Massive
rod photoreceptor death occurs between PD 12 to PD 16. By PD
20, most of the rod photoreceptors are degenerated. Only one
incomplete row of photoreceptor nuclei remains in the outer
nuclear layer (ONL) where photoreceptor cell nuclei reside. By PD
30 and PD 60, even fewer nuclei remain and all appear to be cone
nuclei. In contrast, no significant photoreceptor loss occurs in wild-
type rats from PD 8 to PD 60 (Fig. 2).
To investigate the distribution of COS, we used PNA to identify
COS in whole-mounted retinas. PNA specifically binds to the cone
photoreceptor extracellular matrix and stains COS [32,33]. At PD
10, PNA staining is evenly distributed across the entire retina
(Fig. 3A). Loss of PNA staining first is detected at PD12 when rod
degeneration is at its peak (data not shown). By PD 20, many small
round or irregularly shaped PNA-negative areas were observed,
indicating focal loss of COS (Fig. 3B). The PNA staining outside
the PNA-negative areas is similar to the retina of PD 10. The loss
of PNA staining progresses with age (Fig. 3A–3F), as demonstrated
clearly in the quantitative analysis of COS densities (Fig. 3J). In
comparison, PNA staining in wild-type animals was distributed
evenly without any PNA-negative area (Fig. 3G–3I).
To confirm the specificity of PNA staining of COS, we
performed double-staining experiments with PNA and antibodies
against red/green or blue opsin (Fig. 4). The distribution of red/
green (Fig. 4A) or blue opsin (Fig. 4B) immunostaining overlaps
very well with PNA staining. The specificity of PNA staining of
COS is clearly shown at higher magnification in figure 4C in
which a cone photoreceptor was double-stained with PNA and
antibodies against blue opsin. PNA labeled almost exclusively the
outer segment (Fig. 4C), whereas antibodies against blue opsin
stained not only the outer segment, but also, to a lesser degree, the
inner segment, the cell body, and the synaptic terminal (Fig. 4C).
We next stained cones using antibodies against cone arrestin
(CAR), which specifically stained cone cells from the synaptic
terminals to the outer segment [34]. At PD 20, many CAR-
positive cells were found inside PNA-negative areas (Fig. 5A),
identifying them cones without COS. By PD 90, however, only a
few CAR-positive cells remained in the PNA-negative areas
(Fig. 5B). Thus, by PD 90, most of the cones in the PNA-negative
areas were degenerated. Staining in retinal sections showed that at
Figure 1. Photoreceptor degeneration in homozygous S334ter-
3 rats. Plastic-embedded sections of retinas from S334ter-3 rats of PD 8
(A), 10 (B), 12 (C), 14 (D), 16 (E), 18 (F), 20 (G), 30 (H), and 60 (I) were
examined by light microscopy (superior regions). The outer nuclear
layer (ONL) is indicated in each panel by a white vertical bar. Pyknotic
nuclei are indicated by white arrowheads (B). Loss of photoreceptors
was progressive and by PD 20 most of rod photoreceptors were
degenerated, and the ONL had less than a complete row of nuclei.
Sections were stained with toluidine blue. Scale bar, 20 mm.
doi:10.1371/journal.pone.0009495.g001
Figure 2. Photoreceptors in Sprague-Dawley rats. Plastic-
embedded sections of retinas from wild-type Sprague-Dawley rats of
PD 8 (A), 12 (B), 16 (C), 20 (D), 30 (E), and 60 (F) were examined by light
microscopy (superior regions). The ONL is indicated in each panel by a
white vertical bar. No progressive loss of photoreceptors is observed.
Sections were stained with toluidine blue. Scale bar, 20 mm.
doi:10.1371/journal.pone.0009495.g002
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PD 20, PNA labeling was interrupted by PNA-negative gaps
(Fig. 5C, between two arrows), corresponding to the PNA-negative
areas found in whole-mounted retinas. Many CAR-positive cells
were found inside the PNA-negative gaps (Fig. 5C), consistent with
data from whole-mounted retinas.
In addition, data from retinal sections provided evidence that
PNA-negative areas in the whole-mounted retinas were not an
artifact that might have been resulted from uneven separation of
the retina from the RPE during tissue preparation. In a retinal
detachment created during tissue preparation, the retina was
negative of PNA staining, and so was the overlaying RPE (Fig. 5C,
arrowheads). If the PNA-negative areas were an artifact of uneven
tissue separation, the RPE side would have been PNA positive.
This finding is consistent with results from additional experiments
in which both the retinas and the RPE-choroid preparations were
stained with PNA, but no PNA staining was detected in the RPE-
choroid preparations (data not shown).
CNTF Promotes COS Regeneration
To investigate the effects of CNTF on cone photoreceptors,
retinas were treated with CNTF and examined 10 days later.
When treated with CNTF at PD 10 (endpoint PD 20), PNA
staining was evenly distributed without obvious PNA-negative
areas (Fig. 6A), whereas in PBS-treated fellow eyes, many PNA-
negative areas appeared (Fig. 6D). When treated between the ages
of PD 20 to PD 50 (endpoints PD 30 to PD 60), the PNA-negative
areas became much smaller and in most cases completely
disappeared (Fig. 6B and 6C). In contrast, many PNA-negative
areas were found in the PBS-treated fellow retinas (Fig. 6E and
6F). The CNTF induced increase in PNA staining became less
dramatic at PD 80 (endpoint PD 90, Fig. 6G) and almost no such
increase was seen in retinas of PD 170 (endpoint PD 180, Fig. 6H),
similar to PBS treated fellow retinas (Fig. 6I and 6J, respectively).
The increase in PNA-positive cells in PD 20 and PD 30 retinas
treated with CNTF (Fig. 6B and 6C) indicates that CNTF
treatment not only stopped further degeneration, but also induced
reappearance of PNA staining, suggesting regeneration of COS.
To confirm this observation, eyes were treated with CNTF at PD
35 and retinas were examined at PD 45 for PNA-positive cells.
Indeed, the density of PNA-positive cells in CNTF treated retinas
of PD 45 (Fig. 7C) was more than that in the retina of PD 35
(Fig. 7A) before the treatment. Quantitative analyses showed that
the density of PNA-positive cells in CNTF treated retinas of PD 45
was significantly more than in the PD 35 controls when the
treatment started (Fig. 7D). These results provide evidence that
Figure 3. Loss of COS in the retinas of S334ter-3 rats. Whole-
mounted retinas (superior regions) of S334ter-3 rats (Tg) are shown at
PD 10 (A), 20 (B), 30 (C), 60 (D), 90 (E), and 180 (F), as well as retinas of
wild-type (Wt) rats at PD10 (G), 20 (H), and 60 (I). Retinas were stained
with PNA and examined by confocoal microscopy. In S334ter-3 retinas,
loss of PNA staining is concentrated in small round or irregularly shaped
areas. The loss of PNA staining was progressive with age (A–F).
Quantitative analysis of the density of PNA positive cells in the S334-ter-
3 retinas clearly shows the progressive loss of PNA positive cells in the
superior retina (J, mean 6 SD, n = 4). No such loss of PNA positive cells
was found in wild-type retinas (G–I). Scale bar: 200 mm.
doi:10.1371/journal.pone.0009495.g003
Figure 4. Specificity of PNA staining to COS. Whole-mounted
retinas (superior regions) of S334ter-3 rats (PD 30) were double stained
with PNA and antibodies against red/green opsin (A) or blue opsin (B).
PNA-staining overlaps with red/green opsin or blue opsin staining very
well. The specificity of PNA staining to COS was confirmed under high
magnification (C). PNA stained almost exclusively COS (C), whereas
antibodies against blue opsin stained not only COS, but also, to a lesser
degree, the inner segment, the cell body, and the synaptic terminal (C).
Scale bar: 50 mm for A and B; 10 mm for C.
doi:10.1371/journal.pone.0009495.g004
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CNTF treatment can promote regeneration of COS in degener-
ating cones.
Long-Term Effect of CNTF on Cones
Long-term delivery of CNTF to the retina was achieved by
using CNTF-secreting microdevices [35–37]. Animals were
implanted with CNTF devices in the left eyes and control devices
in the right eyes at PD 20. Eyes were collected at PD160, 140 days
after implantation. Both PNA- and red/green-opsin-positive cells
in the CNTF treated retinas (Fig. 8A and 6B, respectively) were
significantly more than those in the control retinas of the fellow
eyes (Fig. 8C and 8D, respectively). Quantitative analysis shows
that density of PNA-positive or red/green opsin-positive cells in
CNTF treated retinas is significantly more than in the control
retinas (Fig. 8E).
In another experiment, preservation of cone function was
assessed by ERG recording. At PD 30, rats were implanted with
CNTF-secreting devices in the left eyes and devices containing the
parental cells as controls in the right eyes. Cone ERGs were
recorded at PD 135. The cone b-wave amplitude in CNTF-treated
eyes is significantly larger than in control eyes (Fig. 8F and 8G).
Thus, sustained delivery of CNTF helps to preserve the function of
cones as well.
Discussion
The present study demonstrates that the secondary cone
degeneration starts with loss of COS as an early sign, whereas
the actual cell death occurs much later. In the early stages of
degeneration, cones without COS are not only alive and but are
capable of regenerating their outer segments, indicating that at this
time the degeneration process is reversible. Sustained delivery of
CNTF preserves cone cells and their function.
The delay between loss of COS and cell death is likely in the
time frame of about two months in this model. This is based on the
finding that loss of COS is readily observable at PD 20; that retinas
of S334ter-3 rats lack of CAR-positive cells in the PNA-negative
areas at PD 90 (Fig. 3); and that the CNTF-induced regeneration
of COS was dramatically decreased at PD 80 (Fig. 4). The two-
month window is rather large considering the rapid rod
degeneration (about 10 days) in these animals. Thus, secondary
cone degeneration is a relatively slow process, which not only
provides an opportunity to study the pathology of secondary cone
degeneration, but also serves a model for pre-clinical assessment of
potential treatments. Furthermore, this finding raises the possibil-
ity that a similar window may exist in patients with RP. Because of
the slow progression of degeneration in RP patients, this delay in
Figure 5. Loss of COS and cone cells. Whole-mounted retinas
(superior regions) of S334ter-3 rats were double stained with PNA and
antibodies against cone arrestin (CAR). In the retina of PD 20 (A), many
CAR positive cells were found in the PNA-negative areas. In the retina of
PD 90 (B), however, only a few CAR-positive cells remained in the PNA-
negative areas. Cryosections of a PD 20 retina (C) double stained with
PNA and antibodies against CAR showed a gap of PNA staining
corresponding to a negative area seen in whole-mounted retinas (C,
between two arrows). CAR positive cells were found in the gap. The
retina detachment (arrowhead) showed that in the PNA-negative area
(between two arrows), the corresponding RPE side is also negative.
Retinal layers were indicated in C with white vertical bars. PE: RPE; ONL:
outer nuclear layer; INL: inner nuclear layer; IPL: inner plexiform layer;
GCL, ganglion cell layer. Scale bars: 100 mm for A and B; 50 mm for C.
doi:10.1371/journal.pone.0009495.g005
Figure 6. Increase in PNA-positive cells after CNTF treatment.
Retinas (superior regions) of PD 10, 20, 50, 80, and 170 S334ter-3 rats
were treated with either CNTF (left eyes) or PBS (right eyes) and
collected 10 days after treatment. Whole-mounted retinas of PD 20 (i.e.,
injected at PD 10; A, CNTF; D, PBS), PD 30 (B, CNTF; E, PBS), PD 60 (C,
CNTF; F, PBS), PD 90 (G, CNTF; I, PBS), and PD 180 (H, CNTF; J, PBS), were
stained with PNA. Many PNA-negative areas appeared in PBS treated
retinas, whereas no PNA-negative areas were seen in the PD 20 retinas
treated with CNTF (A). The PNA-negative areas became much smaller
and in most cases completely disappeared in PD 30 and 60 retinas
treated with CNTF (B and C). Increase in PNA positive cells after CNTF
treatment became less dramatic in PD 60 retinas (G), and by PD 180 (H),
little or no significant increase is observed. Scale bar: 200 mm.
doi:10.1371/journal.pone.0009495.g006
CNTF and Cone Degeneration
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patients could be very long, which would provide a large window
to allow therapeutic intervention to save cones.
The observation that CNTF stimulated regeneration of COS
demonstrates that in the early stages of degeneration, cones are
capable of regenerating COS under favorable circumstances and
thus the degeneration is reversible. Obviously, this finding has
strong clinical significance. COS are functional organelles that
initiate the conversion of photons to neuronal signals. Without
COS, cones lose their light-sensing function. Regeneration of COS
therefore means that in the early stages of degeneration, cones
may restore their light sensing capabilities and thus restore vision.
In light of this finding, we may want to re-think current
therapeutic strategies for RP. At present, the goal of RP treatment
is to slow down or stop the degeneration. Instead, we perhaps want
to think more about restoring and maintaining useful vision. It is
possible that in RP patients, many degenerating cones retain the
capability of regenerating COS. If that is the case, it may be
possible to promote regeneration of COS and thus restore vision to
some extent for those patients. Consistent with this notion is a
recent finding in a Phase I clinical trial using CNTF for retinal
degenerations, in which one patient with late-stage RP had a
significant improvement of vision [38].
CNTF is a neurotrophic factor that has been shown consistently
to protect rod photoreceptor from degeneration [4–12]. Our
present study demonstrates that sustained delivery of CNTF helps
cones to preserve COS and cone function for an extended period.
These findings provide experimental evidence to support long-
term sustained delivery of neurotrophic factors such as CNTF as a
treatment strategy to benefit RP patients by preserving cone
function and useful vision.
The exact cause of secondary cone degeneration is not clear,
although a number of hypotheses have been proposed, as reviewed
by Delyfer and co-worker [2]. These include the secondary loss of
cones due to 1) toxic byproducts of dying rod photoreceptors; 2)
the loss of structural support by the loss of rods; 3) remodeling as
evidenced by new and abnormal synaptic connections after rod
degeneration; 4) changes in the RPE and Mu¨ller cells due to rod
degeneration; and 5) the loss of rod-derived cone viability factors
(RdCVFs) that are produced by rods and are thought to support
cone survival; loss of rods leads to loss of RdCVFs [39]. In addition
to these possibilities, activation of microglia during rod cell loss
could be a factor [40,41]. Oxidative stress is also believed to cause
secondary cone degeneration: the loss of rods leads to exposure to
a relatively oxygen-rich environment that is detrimental to cones
[42–45]. Yet another potential mechanism of cone cell degener-
ation following rod loss is prolonged starvation due to nutrient
deprivation in cones [46]. While it is unclear whether one or more
of these mechanisms results in secondary cone cell death, the
problem is further complicated by the findings in the present study
of the S334ter-3 rat suggesting that there are two geographically
separated populations of cones in terms of their susceptibility to
Figure 7. Regeneration of COS induced by CNTF treatment.
Retinas (superior regions) of S334ter-3 rats at PD 35 were treated with
either CNTF or PBS and harvested 10 days after treatment. Whole-
mounted retinas of PD 35 (A, before treatment), PD 45 treated with PBS
at PD 35 (B), and PD 45 treated with CNTF at PD 35 (C) were stained
with PNA. PNA positive cells in CNTF treated retinas are more than
those in either PBS treated retinas or PD 35 retinas. Quantitative analysis
showed that PNA-positive cells are significantly more in the PD 45 CNTF
treated retinas (657676, n = 4) than in the PD 35 retinas (467673, n = 3),
or PD 45 retinas treated with PBS (334633, n = 3) (D, mean 6 SD),
indicating regeneration of COS in response to CNTF treatment. Asterisk
indicates P,0.05; double-asterisk indicates P#0.01 (ANOVA analysis
and Bonferroni test). Scale bar: 100 mm.
doi:10.1371/journal.pone.0009495.g007
Figure 8. Long-term effects of sustained delivery of CNTF. Eyes
of S334ter-3 rats were implanted with microdevices containing CNTF-
secreting cells or parental cells at PD 20 and harvested on PD 160.
Whole-mounted retinas (superior regions) were stained with PNA or
antibodies against red/green opsin. PNA or red/green opsin positive
cells are more in the retinas treated with CNTF devices (A and B than
the fellow control retinas (C and D). Quantitative analysis of PNA or red/
green positive cells in the superior retina showed significantly more
cells in CNTF-treated retinas (446680 and 310646, respectively) than
the controls (141640 and 108646, respectively) (E, mean 6 SD, n = 3).
Cone ERGs were recorded at PD 135 from eyes implanted at PD 20 with
CNTF secreting or control devices. Representative b-waves from CNTF
treated and control eyes are shown in panel F. The onset of flash is
indicated by an arrowhead. The amplitudes of b-waves from CNTF
treated retinas (32.46610.02 mV) is significantly larger than from control
retinas (17.7064.78 mV) (G, mean 6 SD, n = 3). Asterisk indicates
P,0.05; double-asterisk indicates P,0.01 (Student t-test). Scale bar:
50 mm.
doi:10.1371/journal.pone.0009495.g008
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the degenerative pressure(s). One population includes cones in the
PNA-negative areas, which are more susceptible to the degener-
ation pressure(s), and the other population that is less susceptible in
the PNA-positive areas. The geographic distribution of cones must
now be taken into consideration when studying cellular mecha-
nisms of cone cell death.
Taken together, the present study demonstrated that an early
sign of cones degeneration is the loss of COS. CNTF promotes
regeneration of COS and protects cone from further degeneration.
Long-term treatment with CNTF starting at an early stage of
degeneration could be a viable strategy for preservation of vision
for RP patients.
Materials and Methods
Ethics Statement
All procedures involving animals adhered to Association for
Research in Vision and Ophthalmology Statement for the Use of
Animals in Ophthalmic and Vision Research and were approved
by the Institutional Animal Care and Use Committee of University
of Miami, Miller School of Medicine.
Animals and Intravitreal Injections
Homozygous transgenic rats (Sprague-Dawley background)
carrying a murine rhodopsin mutant S334ter (line3) and wild-
type Sprague-Dawley (Harlan Laboratories, Indianapolis, IN) rats
were used in all experiments. The rate of photoreceptor
degeneration in the homozygotes was similar to that observed in
heterozygous animals [31]. Intravitreal injections were delivered
through 33-gauge needles connected to 10-ml microsyringes
(Hamilton, Reno, NV), as described previously [29]. One eye
(left) of an animal was injected with recombinant human CNTF
protein and the other with phosphate buffered saline (PBS). Eyes
were collected 10 days after injection.
Recombinant CNTF Protein
Expression and purification of recombinant CNTF protein were
as previously described [29]. The open reading frame of human
CNTF cDNA was cloned into an expression vector pQE30
(Qiagen, Valencia, CA) to generate plasmid pQE-CNTF.
Recombinant human CNTF protein was expressed in E. coli
(XL-blue, Stratagene, La Jolla, CA) and purified by immobilized-
metal affinity chromatography on Ni-NTA Agarose columns
(Qiagen, Valencia, CA) under native conditions. Eluted protein
was buffer-exchanged to phosphate buffered saline (PBS). Purified
protein was stored at 280uC.
Implantation of CNTF Secreting Microdevices
CNTF secreting microdevices, provided by Neurotech USA
(Lincoln, RI), were microtubes of 1.5 mm60.5 mm in size, small
enough for implanting into rat eyes. The wall of the microtubes
was made of 90–100 mm thick semi-permeable hollow-fiber
membrane. CNTF-secreting cells were encapsulated in the devices
using the Encapsulated Cell Technology (ECT) [35–37]. The
devices used in the experiments had a mean CNTF output of
0.8 ng/24 hr in culture. Control devices had parental cells with no
CNTF-secreting capability.
For long-term studies, microdevices were implanted in the
vitreous at postnatal day (PD) 20. To implant a microdevice, the
sclera on the temporal side was exposed and an incision was made
between the limbus and equator with a sharp #28 needle to reach
the vitreous. A microdevice was put into the vitreous through the
insertion at a 45u angle toward the posterior pole. The position of
an implanted microdevice was confirmed visually through the
pupil.
Tissue Preparation and Immunohistochemistry
For whole-mounted retinas, animals were killed by CO2
inhalation and perfused with PBS. Eyecups were prepared by
removing the cornea along the limbus and then the iris. Retina-
lens preparations were obtained by first making a small cut at the
edge of sclera toward the posterior pole. Then with a pair of
forceps at each side of the cut, the sclera, along with the choroid
and RPE (retinal pigment epithelium), was carefully torn open,
and the sclera-choroid-RPE was peered off from the retina-lens to
the base of optic nerve. The sclera-choroid-RPE was then cut off
from the base of optic nerve. The resulted retina-lens preparations
were post-fixed in cold 4% paraformaldehyde solution for 4 hours
at 4uC.
For retinal cryo-sections, animals were killed by CO2 inhalation
and perfused with PBS then 4% paraformaldehyde. Eyes were
collected and the corneas and lenses were removed. The resulted
eyecups were fixed in 4% paraformadehyde in 0.1 M phosphate
buffer for 4 hrs and then equilibrated in 30% sucrose in 0.1 M
phosphate buffer overnight at 4uC. Retinal sections (16 mm) were
cut on a cryostat at 220uC, mounted on Super Frost Plus Gold
slides (Fisher Scientific, Pittsburgh, PA), and air dried overnight at
room temperature (RT).
Peanut agglutinin (PNA) was used to identify COS. For PNA
staining, retina-lens preparations were incubated with FITC-
conjugated (Vector, Burlingame, CA) or Alexa fluor 488-conjugate
(Invitrogen) PNA. The lenses were removed and the retinas were
flat-mounted on slides.
For immunostaining, retina-lens preparations or cryo-sections
were incubated with anti-red/green opsin; anti-blue opsin (Santa
Cruz Biotechnology); or anti-mouse cone arrestin (LUMIJ, a gift of
Dr. Cheryl Craft of the University of Southern California), and
visualized with Alexa Fluor 594 anti-goat IgG (Invitrogen,
Carlsbad, CA) or Cy3 conjugated anti-rabbit antibody (Jackson
immunoresearch lab, West grove, PA). For double-staining with
PNA, Alexa fluor 488-conjugate PNA was added to the secondary
antibody solution. All samples were examined by confocal
microscopy.
Quantification of PNA-Positive Cells
Confocal images from whole mount of retina were used to
calculate the cone cell density (PNA or red/green opsin positive
cells) in the superior retinas using software Volocity (Improvision,
Waltham, MA). Data were expressed as mean6S.D.
ERG Recording
Cone ERGs were recorded with a UTAS system (LKC
Technologies, Gaithersburg, MD). Under Animals were anes-
thetized with intraperitoneal ketamine (80 mg/kg) and xylazine
(4 mg/kg). Pupils were dilated with 0.1% atropine and 0.1%
phenylephrine HCl. During the recording, animals were
maintained at 35uC on a heated plate. A contact lens electrode
with a platinum wire was placed on the cornea, a differential
electrode under the skin of the forehead, and a ground wire
electrode was placed under the skin close to the base of the tail.
Both eyes were recorded simultaneously. Photopic ERG
responses were elicited by 1 ms white flashes of 2.5 log cd?s/m2
generated by white LEDs in the Ganzfeld sphere of the UTAS
system, with low white background illumination (30 cd?s/m2).
Inter-stimulus intervals were 10 s. Each recording was an
average of 10 responses.
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Statistic Analysis
Statistic analyses were performed using InStat (version 3.0,
GraphPad Software Inc., San Diego, CA). Results were evaluated
by ANOVA or Student’s t-test for comparisons between
experimental groups.
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